» Articles » PMID: 30276811

Structural and Functional Neuroimaging in Attention-deficit/hyperactivity Disorder

Overview
Date 2018 Oct 3
PMID 30276811
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Over the last decade, there has been a dramatic increase in the number of neuroimaging studies in attention-deficit/hyperactivity disorder (ADHD). In terms of brain structure, magnetic resonance imaging (MRI), and diffusion tensor imaging studies have evidenced differences in volume, surface-based measures (cortical thickness, surface area, and gyrification), and white matter integrity in different cerebral regions, in children and adults with ADHD compared to population norms. Abnormalities in the basal ganglia, prefrontal structures, and the corpus callosum have been the most consistently reported findings across studies. Hemodynamic (functional MRI, functional near-infrared spectroscopy, positron emission tomography, single-photon emission computed tomography) and magnetoencephalography measurements have also shown differences in neural activity during the execution of neuropsychological tasks and during rest, in widespread regions of the brain. Importantly, multimodal studies combining structural and functional methods have shown an intercorrelation between structural and functional abnormalities in ADHD. Further longitudinal studies are needed to clarify the effects of age and medication on brain structure and function in individuals with ADHD. WHAT THIS PAPER ADDS: In attention-deficit/hyperactivity disorder (ADHD), the brain is characterized by abnormal neural network interplay. Structural and functional cerebral abnormalities in ADHD are intercorrelated. Currently there is no neural biomarker that can be used in diagnosis. Longitudinal studies have shed light on the brain correlates of ADHD over the lifespan. The effects of stimulant intake on the brain correlates of ADHD remain unclear.

Citing Articles

Effects of a novel non-pharmacological intervention based on respiratory biofeedback, neurofeedback and median nerve stimulation to treat children with ADHD.

Santamaria-Vazquez E, Estudillo-Guerra A, Ali L, Martinez D, Hornero R, Morales-Quezada L Front Hum Neurosci. 2025; 19:1478501.

PMID: 39989722 PMC: 11842315. DOI: 10.3389/fnhum.2025.1478501.


The utility of multiple assessments in infancy and toddlerhood to predict middle childhood ADHD symptoms: Temperamental, behavioral, and genetic contributions.

Chromik L, Friedman L, Fabrikant-Abzug G, Davis M, Doane L, Lemery-Chalfant K Infant Behav Dev. 2025; 78:102025.

PMID: 39787630 PMC: 11892346. DOI: 10.1016/j.infbeh.2024.102025.


Research progress of tDCS in the treatment of ADHD.

Huang R, Liu Y J Neural Transm (Vienna). 2024; 132(2):237-251.

PMID: 39508850 PMC: 11785651. DOI: 10.1007/s00702-024-02853-4.


Change in striatal functional connectivity networks across 2 years due to stimulant exposure in childhood ADHD: results from the ABCD sample.

Kaminski A, Xie H, Hawkins B, Vaidya C Transl Psychiatry. 2024; 14(1):463.

PMID: 39505862 PMC: 11541585. DOI: 10.1038/s41398-024-03165-7.


Neural correlates of inattention in adults with ADHD.

Laatsch J, Stein F, Maier S, Matthies S, Sobanski E, Alm B Eur Arch Psychiatry Clin Neurosci. 2024; .

PMID: 39073447 DOI: 10.1007/s00406-024-01872-2.